 Insider Monkey (blog) | 9.1% of TB Drugs Fail Quality Control: Roche Holding Ltd. (ROG) Insider Monkey (blog) Two key anti-TB drugs, isoniazid and rifampicin, originally developed by Roche Holding Ltd. (VTX:ROG), have been shown in a study published this week in the International Journal of Tuberculosis and Lung Disease to be increasingly compromised. AEI's ... |
